• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量静脉注射免疫球蛋白治疗输血后紫癜

High-dose intravenous immunoglobulin for post-transfusion purpura.

作者信息

Becker T, Panzer S, Maas D, Kiefel V, Sprenger R, Kirschbaum M, Mueller-Eckhardt C

出版信息

Br J Haematol. 1985 Sep;61(1):149-55. doi: 10.1111/j.1365-2141.1985.tb04071.x.

DOI:10.1111/j.1365-2141.1985.tb04071.x
PMID:4052323
Abstract

Five patients with post-transfusion purpura (four due to Zw(a), one presumably due to HLA antibodies) were treated with intravenous immunoglobulin (IgG) at doses of 0.4 g per kg body weight. IgG therapy was immediately effective as indicated by cessation of bleeding and rise of platelet counts in four out of five cases.

摘要

五名输血后紫癜患者(四名因Zw(a),一名可能因HLA抗体)接受了静脉注射免疫球蛋白(IgG)治疗,剂量为每公斤体重0.4克。五例中有四例出血停止且血小板计数上升,表明IgG治疗立即起效。

相似文献

1
High-dose intravenous immunoglobulin for post-transfusion purpura.大剂量静脉注射免疫球蛋白治疗输血后紫癜
Br J Haematol. 1985 Sep;61(1):149-55. doi: 10.1111/j.1365-2141.1985.tb04071.x.
2
High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura.免疫性血小板减少性紫癜患者的大剂量静脉注射免疫球蛋白治疗
JAMA. 1983 Apr 1;249(13):1748-50.
3
Persistent remission of adult chronic autoimmune thrombocytopenic purpura after treatment with high-dose intravenous immunoglobulin.大剂量静脉注射免疫球蛋白治疗后成人慢性自身免疫性血小板减少性紫癜的持续缓解
Am J Hematol. 1987 Jul;25(3):271-5. doi: 10.1002/ajh.2830250306.
4
Idiopathic thrombocytopenic purpura and IgG: a review.特发性血小板减少性紫癜与免疫球蛋白G:综述
J Infect. 1987 Jul;15 Suppl 1:41-9. doi: 10.1016/s0163-4453(87)92469-8.
5
Post-transfusion purpura responding to high dose intravenous IgG: further observations on pathogenesis.对大剂量静脉注射免疫球蛋白有反应的输血后紫癜:关于发病机制的进一步观察
Br J Haematol. 1985 Dec;61(4):627-32. doi: 10.1111/j.1365-2141.1985.tb02876.x.
6
A new IVIgG preparation (IVIgG pH 4.25): preliminary results for the treatment of immune thrombocytopenia.一种新型静脉注射免疫球蛋白制剂(静脉注射免疫球蛋白pH 4.25):治疗免疫性血小板减少症的初步结果。
J Infect. 1987 Jul;15 Suppl 1:51-4. doi: 10.1016/s0163-4453(87)92480-7.
7
Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults.
Am J Med. 1987 Oct 23;83(4A):17-24. doi: 10.1016/0002-9343(87)90546-8.
8
Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura.静脉注射免疫球蛋白治疗慢性特发性血小板减少性紫癜的临床疗效
Blut. 1983 Aug;47(2):69-75. doi: 10.1007/BF02482640.
9
Treatment of severe chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous gammaglobulin.大剂量静脉注射丙种球蛋白治疗成人重度慢性特发性血小板减少性紫癜
Scand J Haematol. 1985 Feb;34(2):128-32. doi: 10.1111/j.1600-0609.1985.tb02244.x.
10
[Idiopathic autoimmune thrombopenic purpura and pregnancy].
Nouv Rev Fr Hematol (1978). 1987;29(6):401-5.

引用本文的文献

1
Post-transfusion purpura and adult primary thrombocytopenia.输血后紫癜与成人原发性血小板减少症。
Int J Hematol. 2024 Jul;120(1):146. doi: 10.1007/s12185-024-03784-2. Epub 2024 Apr 29.
2
[Pediatric expert consensus on the application of intravenous immunoglobulin in children with hematological/neoplastic diseases].《静脉注射免疫球蛋白在儿童血液系统/肿瘤性疾病中应用的儿科专家共识》
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Apr;23(4):319-327. doi: 10.7499/j.issn.1008-8830.2101174.
3
Post-Transfusion Purpura: Current Perspectives.输血后紫癜:当前观点
J Blood Med. 2019 Dec 9;10:405-415. doi: 10.2147/JBM.S189176. eCollection 2019.
4
New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach.住院患者新发急性血小板减少症:病理生理学与诊断方法
J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):157-167. doi: 10.1080/20009666.2017.1335156. eCollection 2017 Jul.
5
Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia.输血后紫癜:一种罕见且危及生命的血小板减少病因。
BMJ Case Rep. 2013 May 24;2013:bcr2013008860. doi: 10.1136/bcr-2013-008860.
6
Evidence for the use of intravenous immunoglobulins--a review of the literature.静脉注射免疫球蛋白的应用证据——文献综述。
Clin Rev Allergy Immunol. 2010 Apr;38(2-3):201-69. doi: 10.1007/s12016-009-8155-9.
7
Neonatal allo-immune thrombocytopenia due to fetomaternal HPA-1 incompatibility of a homozygous HPA-1a mother and a homozygous HPA-1b father. A case report.由于纯合子HPA-1a母亲和纯合子HPA-1b父亲之间的母婴HPA-1不相容性导致的新生儿同种免疫性血小板减少症。病例报告。
Eur J Pediatr. 1994 Feb;153(2):95-7. doi: 10.1007/BF01959215.
8
Posttransfusion purpura. A survey of 13 cases.输血后紫癜。13例病例调查。
Klin Wochenschr. 1986 Nov 17;64(22):1198-203. doi: 10.1007/BF01728461.
9
Immune phagocytosis inhibition by commercial immunoglobulins.商业免疫球蛋白对免疫吞噬作用的抑制
Blut. 1986 Feb;52(2):67-72. doi: 10.1007/BF00321069.
10
Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.静脉注射免疫球蛋白用于自身免疫性疾病的治疗。
J Clin Immunol. 1990 Mar;10(2):81-9. doi: 10.1007/BF00918189.